SEQUITUR INC has a total of 20 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are INGENE INC, ROSSI JOHN J and QUARK PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | United States | 4 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Woolf Tod M | 19 |
#2 | Beck Terry B | 3 |
#3 | Wiederholt Kristin | 3 |
#4 | Taylor Margaret | 3 |
#5 | Taylor Margaret F | 3 |
#6 | Wiederholt Kristin A | 3 |
#7 | Woolf Tod | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007200178A1 | Sense mrna therapy | |
US2003031655A1 | Methods of light activated release of ligands from endosomes | |
AU6400600A | Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets | |
AU4225200A | Improved antisense oligomers |